10/10/2023Sanofi, BioMap Partner to Develop Drug Discovery AI Modules

10/10/2023Bayer Pledges to Make More Investment in China

10/9/2023MNCs Wary of Pouring Big Investments in China While Actively Seeking L...

10/9/2023NHSA Solicits Comments on Draft of the Guiding Opinions on Strengtheni...

10/8/2023Recent Executive Movements

10/8/2023PharmaEssentia Enters Global License Deal with WuXi Bio for a Myeloid ...

10/7/2023CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...

10/4/2023PharmCube: Review of Chinese Hospital Drug Market MAT Q2/2023 (1)

10/4/2023Sales Expenses of 489 Chinese Pharma Cos Exceed CNY 170B in H1/2023

10/3/2023CNIPA Invalides Novo's Core Chinese Patent for Semaglutide as Petition...

9/29/2023Recent Executive Moves

9/29/2023Financial-related Company News Digest (September 2023)

9/28/2023Chime Biologics Enters Strategic Deal with Kings Pharm to Accelerate B...

9/28/2023CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...

9/28/2023CDE Solicits Comments on the Technical Guidelines for Clinical Efficac...

9/26/2023China's Shifting Cost Dynamic to Help It Develop Own Biologics Niche: ...

9/26/2023China Becomes Country with Highest and Increasingly Younger Alzheimer ...

9/26/2023SAMR Imposed Fines and Confiscations Totaling Over CNY 300 Million in...

9/26/2023WuXi Debuts First Vaccine CDMO Site in China

9/26/2023AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...

9/25/2023AbbVie Terminates Deal with I-Mab to Exit Race for CD47 Space

9/25/2023CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...

9/24/2023Chime Biologics Enter Global Strategic Deal with Panolos for Multi-spe...

9/24/2023PackGene and Kudo Partner to Offer Customized mRNA Manufacturing Servi...

9/24/2023Strategies for Asian Business Navigating a New Era (McKinsey)

9/24/2023Improving Access to Medicines and Beyond: the National Volume-based Pr...

9/21/2023Meitheal Licenses U.S. Rights of Insulin Biosimilars from Tonghua Dong...

9/21/2023Recent Executive Moves

9/20/2023NHSA Clears Two Additional Drugs from Form Evaluation for 2023 NRDL In...

9/20/2023Everest Medicines Enters into Collaboration and License Agreement with...

Page:39/354 Total number of articles:10619: [First][<<] [37] [38] [39] [40] [41] [>>] [End]